Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes - Wikidata - wikimedia - TriplyDB

Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes

Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes

http://www.wikidata.org/entity/Q58771283

about

Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes

http://www.wikidata.org/entity/Q58771283

description

article publié dans la revue scientifique Scientific Reports

@fr

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Scientific Reports

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Physiologically based pharmaco ...... ith regard to CYP2D6 genotypes

@en

Physiologically based pharmaco ...... ith regard to CYP2D6 genotypes

@nl

type

label

Physiologically based pharmaco ...... ith regard to CYP2D6 genotypes

@en

Physiologically based pharmaco ...... ith regard to CYP2D6 genotypes

@nl

prefLabel

Physiologically based pharmaco ...... ith regard to CYP2D6 genotypes

@en

Physiologically based pharmaco ...... ith regard to CYP2D6 genotypes

@nl

P1433

Q58771283-9AB45310-A2EF-4AAC-AEAA-B945CCF31E0D

P1476

Q58771283-914309FC-5002-4342-8A47-444C77FF54E1

P2093

Q58771283-16693795-2EF3-499E-B39B-91EC7BEE7B2A

Q58771283-185DE131-8ED6-4909-BC89-1CB1C3FC0BC1

Q58771283-236CE3B8-66AA-469C-9F7E-F70A524D8C13

Q58771283-985B632C-9181-49D9-848C-D5E744E86298

Q58771283-D5BFCBBD-3993-4705-A5A1-6B34E2186290

Q58771283-D919D2E9-C466-46E6-849E-DD84963F418D

P2860

Q58771283-11C3CAFD-9EF4-4805-88F6-BCF03DA38A7C

Q58771283-21422A95-6579-46B5-B77F-CCB9C27FDCF8

Q58771283-291CB6CA-0C00-4F85-9B31-9904F2552512

Q58771283-2A548C53-50BA-4446-84A8-87A7EE9E47E0

Q58771283-30408D1A-C1C2-417B-95BE-9D9FF5E3C6B7

Q58771283-38CCA4AB-CDA1-4584-A978-84DC85835468

Q58771283-3F2648CD-AF74-4CFB-A9B6-C06AFC8C63A9

Q58771283-5ED219AF-F408-43F8-BF7C-67392F324084

Q58771283-66466C67-4C96-4475-9088-2592E2C07EA7

Q58771283-6A3A90AD-9C16-4EDC-B120-73A2705080A5

P304

Q58771283-314D5267-3325-4B3B-BEAA-9EA39EB74138

P31

Q58771283-11F8D868-E6C1-4AA1-9B33-54FC5D4AE776

P356

Q58771283-EA007150-A192-40CB-B3F9-642ED3D09BB0

P407

Q58771283-7619ECC9-2101-428D-A3CA-3FF578696BCB

P433

Q58771283-6A3FA1BB-4D06-4B9C-9D78-7C7F76E65584

P478

Q58771283-C2528A84-F80C-4B9A-8178-CA67C0D65416

P50

Q58771283-AF3A34CE-554B-4870-840E-C1B31631539E

P577

Q58771283-B7C8C32A-A9E8-4B8F-899F-56170E7750F7

P698

Q58771283-866D5771-CC49-4B76-8BC0-F8357CA0A2CC

P932

Q58771283-01BACBDE-6411-4700-9FF6-372D7E4BACFE

P356

S41598-018-30841-8

P1433

Scientific Reports

P1476

Physiologically based pharmaco ...... ith regard to CYP2D6 genotypes

@en

P2093

Choon-Gon Jang

http://www.w3.org/2001/XMLSchema#string

Choong-Min Lee

http://www.w3.org/2001/XMLSchema#string

Ji-Young Byeon

http://www.w3.org/2001/XMLSchema#string

Se-Hyung Kim

http://www.w3.org/2001/XMLSchema#string

Young-Hoon Kim

http://www.w3.org/2001/XMLSchema#string

Yun Jeong Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17

Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals

A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.

Clinical pharmacokinetics of atomoxetine.

Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.

Physiologically Based Pharmacokinetic Modeling of Tamoxifen and its Metabolites in Women of Different CYP2D6 Phenotypes Provides New Insight into the Tamoxifen Mass Balance.

Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6*10 allele

Single dose, CYP2D6 genotype-stratified pharmacokinetic study of atomoxetine in children with ADHD

Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in Children.

Physiologically Based Pharmacokinetic (Pbpk) Model of the Cyp2d6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions.

P304

12405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-30841-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30120390

http://www.w3.org/2001/XMLSchema#string

P932

6098032

http://www.w3.org/2001/XMLSchema#string